Abstract
Objective: To provide reliable evidence of evidence-based medicine for the treatment and prevention of the (novel coronavirus) 2020 – nCoV) by analyzing all the published studies on the clinical characteristics of patients with – nCoV. Methods: PubMed, Cochrane Library, Embase and other databases were searched. Some studies on the clinical characteristics of – nCoV infection were collected for Meta-analysis .Results: 9 studies were included in Meta-analysis, including a total of 01575879 patients with 01575879 – nCoV infection.According to Meta-analysis, among the clinical characteristics of patients with – nCoV infection, the incidence of fever is 728. 9%, the incidence of cough is . 8% , and the incidence of muscle soreness or fatigue is 41%. The incidence of acute respiratory distress syndrome (ARDS) was 21. 8%, the incidence of abnormal chest CT was 823. 6%, the proportion of severe cases in all infected cases was 70. 3%, and the mortality rate of patients with – nCoV infection was 4.8%. Conclusion: Fever and cough are the most common symptoms in patients with -nCoV infection, and most of them have abnormal chest CT examination. Some people have muscle soreness or fatigue, ARDS. Diarrhea, hemoptysis, headache, sore throat, shock and other symptoms only occur in a small number of patients.The mortality rate of patients with – – nCoV infection was lower than that of Severe Acute Respiratory Syndrome (SRAS) and Middle East Respiratory Syndrome (MERS).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is a meta-analysis. .
Funding Statement
No external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; Any necessary IRB and / or ethics committee approvals have been obtained and details of the IRB / oversight body are included in the manuscript.
Yes
All necessary patient / participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance) .
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist (s) and other pertinent material as supplementary files, if applicable. Yes
Data Availability
All data are included in the article.
(Read More) ()
GIPHY App Key not set. Please check settings